VREO — Vireo Growth Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSuper Stock

Annual balance sheet for Vireo Growth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	7.64	25.5	15.2	15.1	16
Net Total Accounts Receivable
Net Total Receivables	1.03	0.991	4.5	4.29	19.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	27.2	47	41.6	46.7	149
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.9	38.7	108	95.7	25.3
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	85.4	103	167	159	183
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.76	19.9	16.4	29.7	179
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	36.7	40.3	124	156	199
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	48.7	62.3	43	3.44	-16
Total Liabilities & Shareholders' Equity	85.4	103	167	159	183
Total Common Shares Outstanding